Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction. Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global...
Aspect Biosystems’ $2.7 Billion Collaboration with Novo Nordisk
Replay’s $55 Million Seed Funding
Wilson Sonsini advised Replay on the deal. Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million...